Cannabis Reforms Drive Decline in Tobacco Use, Unveiling Potential $10 Billion Healthcare Savings
State-level cannabis reforms are revolutionizing public health as a groundbreaking study reveals a remarkable decline in tobacco use. Contrary to concerns expressed by some experts, the legalization of marijuana is associated with small, yet significant, long-term reductions in adult tobacco consumption. This comprehensive research, published in the Journal of Health Economics, is the first of its kind to explore the impact of recreational marijuana legalization on tobacco use. By analyzing federal data from the Population Assessment of Tobacco and Health (PATH) and the National Survey on Drug Use and Health (NSDUH), researchers from Bentley, San Diego State, and Georgia State universities unearthed astonishing insights.
The study findings indicate that the adoption of state recreational marijuana laws (RMLs) has a minimal impact on adult cannabis use, showing an increase of approximately two to four percentage points, depending on the data source. However, tobacco use does not follow this trend, disproving concerns of marijuana legalization fueling tobacco consumption.
If this substitution effect from cigarettes to marijuana, triggered by legalization, expands nationwide, it could yield healthcare cost savings surpassing $10 billion annually. The study emphasizes that recreational marijuana laws may indeed generate substantial tobacco-related health benefits.
Addressing the cautious approach taken by public health experts amid the surge in public support for cannabis legalization, the researchers acknowledge the necessity for further research to assess the health costs and benefits of marijuana use, as well as its potential unintended consequences on other health behaviors. The notion of “renormalization” of smoking, potentially reversing decades of declining cigarette use, has been raised as a concern. Nonetheless, the study acknowledges the remarkable decline in smoking rates since the initial Surgeon General’s report in 1964, with male adult smoking rates dropping from 55 percent to 16 percent and female smoking rates declining from 35 percent to 12 percent.
Analyzing the National Survey on Drug Use and Health (NSDUH) data, the study reveals a statistically insignificant decline in tobacco use of approximately 0.5 to 0.7 percentage points following marijuana legalization. However, this seemingly null effect conceals small, but consequential, lagged tobacco effects of RMLs. Remarkably, three or more years after the enactment of an RML, adult tobacco use experiences a notable decline of approximately 1.4 to 2.7 percentage points.
Specifically focusing on cigarette use, the study unveils a statistically significant decline of 1.1 to 1.3 percentage points among adults three or more years following RML enactment. Moreover, when analyzing states that legalized cannabis earlier than others, substantial declines in tobacco use were observed, especially in Colorado and Washington—states experiencing the most significant increases in marijuana use post-RML enactment.
Interestingly, the study reveals that the reduction in tobacco use in legal states is primarily concentrated among men and in RMLs accompanied by open recreational dispensaries. These findings support the hypothesis that recreational marijuana and tobacco may serve as substitutes for some adults.
Moreover, the research highlights the potential healthcare cost savings resulting from the shift away from cigarettes towards cannabis, which could be substantial. Estimates suggest a reduction in smoking prevalence by as many as 5.1 million, potentially leading to tobacco-related healthcare cost savings of approximately $10.2 billion per year.
It’s important to note that as most states with legal cannabis initially passed medical marijuana laws (MMLs), there is a possibility that the effects of RMLs could be conflated with the long-term impacts of MMLs. Delays between legalizing medical marijuana and commencing legal sales contribute to this conflation.
The study’s analysis of the Population Assessment of Tobacco and Health (PATH) data aligns with the NSDUH findings, showing no evidence that RML adoption significantly increased combustible tobacco use or e-cigarette use. Although estimated lagged effects occasionally show slight increases in cigarette use, cigar use, and other combustible tobacco products, these effects are consistently below one percentage point and not statistically distinguishable from zero at conventional levels.
Additionally, the study finds no evidence that RML adoption significantly stimulates the initiation of tobacco products among baseline non-users or decreases cessation among baseline tobacco users.
While joint use of tobacco and marijuana experiences a 1.2 to 1.3 percentage point increase following legalization, this primarily stems from marijuana initiation among individuals who were already using tobacco before the policy shift.
In line with the shifting perceptions, a Gallup poll published last year revealed that more Americans now smoke marijuana than cigarettes, and a Monmouth University survey from October found that most Americans believe alcohol and tobacco are more dangerous than cannabis.
Adding to the growing body of evidence, a federally funded study earlier this year discovered that CBD could help reduce nicotine cravings and aid individuals in quitting smoking.
In conclusion, this groundbreaking study unveils the transformative impact of state-level cannabis reforms on reducing tobacco use. With the potential for substantial healthcare cost savings exceeding $10 billion annually, the findings shed light on the significant health benefits that recreational marijuana laws can generate. As the nation continues to evolve its stance on cannabis, further research is essential to comprehend the intricate dynamics and potential implications for public health.
